Share Share on Facebook Share on Twitter Pinterest Email Cleo Diagnostics (COV:AU) has announced The Royal Women’s Hospital Joins CLEO Ovarian Cancer Trial Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Silver Crown Royalties Announces Corporate Update January 11, 2025 Lead Price Forecast: Top Trends for Lead in 2025 January 11, 2025 5 Best-performing Canadian Pharma Stocks of 2025 January 11, 2025